- Home
- CHE vs G Comparison
CHE vs G Comparison
Compare CHE & G Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHE
- G
- Stock Information
- Founded
- CHE 1970
- G 1997
- Country
- CHE United States
- G Bermuda
- Employees
- CHE N/A
- G N/A
- Industry
- CHE Medical/Nursing Services
- G Professional Services
- Sector
- CHE Health Care
- G Consumer Discretionary
- Exchange
- CHE Nasdaq
- G Nasdaq
- Market Cap
- CHE 8.6B
- G 8.2B
- IPO Year
- CHE N/A
- G 2007
- Fundamental
- Price
- CHE $566.87
- G $45.62
- Analyst Decision
- CHE Buy
- G Hold
- Analyst Count
- CHE 2
- G 9
- Target Price
- CHE $641.50
- G $42.33
- AVG Volume (30 Days)
- CHE 87.0K
- G 1.6M
- Earning Date
- CHE 10-29-2024
- G 11-07-2024
- Dividend Yield
- CHE 0.32%
- G 1.34%
- EPS Growth
- CHE 22.57
- G 58.45
- EPS
- CHE 19.78
- G 3.66
- Revenue
- CHE $2,377,206,000.00
- G $4,664,651,000.00
- Revenue This Year
- CHE $8.28
- G $8.18
- Revenue Next Year
- CHE $7.06
- G $6.59
- P/E Ratio
- CHE $28.63
- G $12.48
- Revenue Growth
- CHE 6.83
- G 5.22
- 52 Week Low
- CHE $523.33
- G $30.23
- 52 Week High
- CHE $654.62
- G $47.98
- Technical
- Relative Strength Index (RSI)
- CHE 49.63
- G 63.08
- Support Level
- CHE $567.81
- G $43.84
- Resistance Level
- CHE $578.73
- G $47.07
- Average True Range (ATR)
- CHE 9.10
- G 0.80
- MACD
- CHE 2.21
- G -0.11
- Stochastic Oscillator
- CHE 58.62
- G 55.11
About CHE Chemed Corp
Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.
About G Genpact Limited
Genpact Ltd is a provider of business process management services. Clients are industry verticals and operate in banking and financial services, insurance, capital markets, consumer product goods, life sciences, infrastructure, manufacturing and services, healthcare, and high-tech. Genpact's services include aftermarket, direct procurement, risk and compliance, human resources, IT, industrial solutions, collections, finance and accounting, and media services. Genpact's end market by revenue is India. It is a General Electric spin-off, which is still a large source of revenue for Genpact.